KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Raw Materials (2016 - 2018)

Bausch Health Companies' Raw Materials history spans 7 years, with the latest figure at $275.0 million for Q4 2018.

  • For Q4 2018, Raw Materials changed 0.36% year-over-year to $275.0 million; the TTM value through Dec 2018 reached $275.0 million, changed 0.36%, while the annual FY2018 figure was $275.0 million, 0.36% changed from the prior year.
  • Raw Materials for Q4 2018 was $275.0 million at Bausch Health Companies, down from $284.0 million in the prior quarter.
  • Across five years, Raw Materials topped out at $290.0 million in Q1 2018 and bottomed at $191.1 million in Q4 2014.
  • The 5-year median for Raw Materials is $275.0 million (2018), against an average of $266.2 million.
  • The largest annual shift saw Raw Materials decreased 13.84% in 2014 before it skyrocketed 51.23% in 2015.
  • A 5-year view of Raw Materials shows it stood at $191.1 million in 2014, then surged by 51.23% to $289.0 million in 2015, then decreased by 11.42% to $256.0 million in 2016, then grew by 7.81% to $276.0 million in 2017, then decreased by 0.36% to $275.0 million in 2018.
  • Per Business Quant, the three most recent readings for BHC's Raw Materials are $275.0 million (Q4 2018), $284.0 million (Q3 2018), and $274.0 million (Q2 2018).